Your browser doesn't support javascript.
loading
The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas.
Croce, Sabrina; Lesluyes, Tom; Valle, Carine; M'Hamdi, Loubna; Thébault, Noémie; Pérot, Gaëlle; Stoeckle, Eberhard; Noël, Jean-Christophe; Fontanges, Quitterie; Devouassoux-Shisheboran, Mojgan; Querleu, Denis; Guyon, Frédéric; Floquet, Anne; Chakiba, Camille; Mayeur, Laetitia; Rebier, Flora; MacGrogan, Gaëtan Marie; Soubeyran, Isabelle; Le Guellec, Sophie; Chibon, Frédéric.
Afiliação
  • Croce S; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France. s.croce@bordeaux.unicancer.fr.
  • Lesluyes T; INSERM U1218, Bordeaux, France.
  • Valle C; University of Bordeaux, Bordeaux, France.
  • M'Hamdi L; Oncosarc, INSERM UMR1037, Cancer Research Center of Toulouse, Toulouse, France.
  • Thébault N; Department of Pathology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse France.
  • Pérot G; Plateau Génomique et Transcriptomique, INSERM U1037, Cancer Research Center of Toulouse, Toulouse, France.
  • Stoeckle E; Department of Pathology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse France.
  • Noël JC; Oncosarc, INSERM UMR1037, Cancer Research Center of Toulouse, Toulouse, France.
  • Fontanges Q; Oncosarc, INSERM UMR1037, Cancer Research Center of Toulouse, Toulouse, France.
  • Devouassoux-Shisheboran M; Department of Pathology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse France.
  • Querleu D; Department of Surgery, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.
  • Guyon F; Department of Pathology, Clinic of Gynecopathology and Senology, Erasme University Hospital, Brussels, Belgium.
  • Floquet A; Department of Pathology, Clinic of Gynecopathology and Senology, Erasme University Hospital, Brussels, Belgium.
  • Chakiba C; Department of Pathology, CHU Lyon Sud, Pierrebenite, France.
  • Mayeur L; Department of Surgery, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.
  • Rebier F; Department of Surgery, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.
  • MacGrogan GM; Department of Oncology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.
  • Soubeyran I; Department of Oncology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.
  • Le Guellec S; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.
  • Chibon F; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.
Clin Cancer Res ; 26(4): 855-861, 2020 02 15.
Article em En | MEDLINE | ID: mdl-31796515
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Leiomiossarcoma / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Leiomiossarcoma / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França